Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy
Objective: To investigate the potential mechanisms underlying the protective effects of recombinant human erythropoietin (rhEPO) and carbamylated EPO (CEPO) against myocardial cell apoptosis in epilepsy. Methods: Rats were given an intra-amygdala injection of kainic acid to induce epilepsy. Groups o...
Main Authors: | Bao-Xin Ma, MD, Jie Li, MD, Hua Li, MD, Sui-Sheng Wu, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | Current Therapeutic Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X15000090 |
Similar Items
-
Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo
by: Samaka RM, et al.
Published: (2019-06-01) -
Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris
by: Farag AGA, et al.
Published: (2019-07-01) -
Erythropoietin Attenuates Experimental Contrast-Induced Nephrology: A Role for the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling Pathway
by: Jia Yang, et al.
Published: (2021-04-01) -
Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes
by: Ankit Srivastava, et al.
Published: (2018-05-01) -
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01)